Skip to content

American CryoStem Corporation: 10-Q filed 2017-05-22

What American CryoStem Corporation reported in its quarterly report filed 2017-05-22 (fiscal Q2 2017): 31 published measures, 82 facts as tagged in accession 0001019056-17-000476.

This filing

Form
10-Q (quarterly report)
Filed
2017-05-22
Fiscal period
fiscal Q2 2017
Accession
0001019056-17-000476 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All American CryoStem Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-03-31744,280USD
At 2016-09-30591,921USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-03-31-1,852,719USD
At 2016-09-30-1,946,754USD
At 2016-03-31-1,653,752USD
At 2015-09-30-1,631,348USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-03-31101,542USD
At 2016-09-3037,251USD
At 2016-03-3120,462USD
At 2015-09-309,059USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-12,307USD90
2016-10-01 to 2017-03-31-107,588USD182
2016-01-01 to 2016-03-31-139,200USD91
2015-10-01 to 2016-03-31-212,767USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-10-01 to 2017-03-31-29,178USD182
2015-10-01 to 2016-03-31-303,898USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-10-01 to 2017-03-318,318USD182
2015-10-01 to 2016-03-311,131USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-10-01 to 2017-03-31128,021USD182
2015-10-01 to 2016-03-31319,622USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-10-01 to 2017-03-31-34,552USD182
2015-10-01 to 2016-03-31-4,321USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-03-31-11,531,748USD
At 2016-09-30-11,424,158USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-03-31171,449USD
At 2016-09-30182,701USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-03-3128,584USD90
2016-10-01 to 2017-03-31-34,971USD182
2016-01-01 to 2016-03-31-166,677USD91
2015-10-01 to 2016-03-31-216,094USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-03-31265,658USD
At 2016-09-30127,284USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-10-01 to 2017-03-3172,617USD182
2015-10-01 to 2016-03-3150,521USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-03-312,485,505USD
At 2016-09-301,272,991USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-03-31134,171USD
At 2016-09-3065,335USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-01-01 to 2017-03-31251,171USD90
2016-10-01 to 2017-03-31511,892USD182
2016-01-01 to 2016-03-31237,312USD91
2015-10-01 to 2016-03-31347,227USD183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-03-3127,144USD
At 2016-09-3024,698USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-01-01 to 2017-03-31279,755USD90
2016-10-01 to 2017-03-31476,921USD182
2016-01-01 to 2016-03-3170,635USD91
2015-10-01 to 2016-03-31131,133USD183

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2017-01-01 to 2017-03-31149,916USD90
2016-10-01 to 2017-03-31273,221USD182
2016-01-01 to 2016-03-3169,805USD91
2015-10-01 to 2016-03-31148,421USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-01-01 to 2017-03-3159,888USD90
2016-10-01 to 2017-03-31101,477USD182
2016-01-01 to 2016-03-3144,981USD91
2015-10-01 to 2016-03-3167,912USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-03-3137,995,091shares
At 2016-09-3037,121,709shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-03-319,641,034USD
At 2016-09-309,440,282USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-03-31420,960USD
At 2016-09-30405,332USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-03-31249,511USD
At 2016-09-30229,942USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2016-10-01 to 2017-03-31-107,588USD182
2015-10-01 to 2016-03-31-212,767USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-03-31163,616USD90
2016-10-01 to 2017-03-31300,311USD182
2016-01-01 to 2016-03-31147,768USD91
2015-10-01 to 2016-03-31232,942USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-10-01 to 2017-03-3120,567USD182
2015-10-01 to 2016-03-3119,816USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-01-01 to 2017-03-31-40,891USD90
2016-10-01 to 2017-03-31-72,617USD182
2016-01-01 to 2016-03-3127,477USD91
2015-10-01 to 2016-03-313,327USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2016-10-01 to 2017-03-31135,625USD182
2015-10-01 to 2016-03-31190,363USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-10-01 to 2017-03-3181,456USD182
2015-10-01 to 2016-03-31-51,110USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-10-01 to 2017-03-312,446USD182
2015-10-01 to 2016-03-310USD183

Inspect the source

Entity
American CryoStem Corporation / CIK 0001468679
Captured
SEC response SHA-256
989d6940bd454aa52ced7069bb00d7059fedcf39f5e0d0c504f9fa725c0cf4b0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001468679.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))